Glenmark’s consolidated revenue up by 6.22% in Q3

Glenmark Pharmaceuticals announced its results for the third quarter ended December 31, 2014.


For the third quarter ended December 31, 2014, Glenmark's consolidated revenue was at Rs 17,013.07 Mn ($274.80 Mn) as against Rs 16,017.52 Mn ($259.64 Mn) an increase of 6.22 percent.

The consolidated Net Profit was at Rs 1,147.60 Mn for the quarter ended Dec 31, 2014 as compared to Rs 2,143.31 Mn for the previous corresponding quarter.

The profits for the quarter are not comparable because of foreign exchange losses in Emerging Markets especially Russia, said company in its statement.

Business Highlights:

• India Business grew by 13.60 percent to Rs 4,330.73 Mn
• Europe Formulations Business grew by 27.33 percent to Rs 1729.54 Mn
• Latin America Business grew by 105.77 percent to Rs 2,344.40 Mn


Previous 1 3 4 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email